INTRODUCTION
Phase angle (PA) is an indicator determined by bioelectrical impedance analysis (BIA), and is associated with membrane integrity, body cell mass, and fluid balance (1). These parameters can help the health team to estimate a patient’s clinical and surgical prognosis. Some studies have been conducted with postoperative, oncological, HIV, and dialytic patients, showing a reduction in cellularity under these critical conditions (2,3).
Obese patients frequently present a chronic inflammatory process characterized by increased proinflammatory and decreased anti-inflammatory cytokine levels, leading to poor glycemic control, dyslipidemia, hyperuricemia, and endothelial damage. All these conditions are associated with atherosclerosis, explaining the higher risk for a cardiovascular event, the main cause of death among obese patients (4,5). This subclinical inflammation status increases the production of reactive oxygen species (ROS) that oxidize lipids and proteins, including those in the cell membrane, which decreases cellularity (6) and interferes in their phase angle values.
Therefore, the aim of this study was to investigate the possible association between phase angle, as an indicator of cellular integrity, and metabolic parameters in severely obese patients.
MATERIALS AND METHODS
STUDY POPULATION AND SAMPLE
This cross-sectional study enrolled severely obese patients who consecutively attended a center specializing in the treatment of obesity from January 2014 to July 2016. A multidisciplinary team assessed and recorded the clinical, biochemical, anthropometric, and segmented electric bioimpedance parameters routinely used by the clinic.
The sample included individuals with BMI (body mass index) ≥ 35 kg/m2; ≥ 18 years old; without cardiac, hepatic, pancreatic, renal or pulmonary insufficiency; who underwent a segmented electric bioimpedance assessment in the clinic.
VARIABLES
We analyzed the possible association between phase angle and fasting blood glucose, glycated hemoglobin (HbA1c), homeostatic model assessment for insulin resistance (HOMA-IR), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), total cholesterol, non-HDL cholesterol, and uric acid. The association between phase angle and some components of body composition was also evaluated. All these variables are related to higher cardiovascular risk, and are routinely evaluated in the preoperative workup of very obese patients.
HOMA-IR was calculated using the formula: HOMA-IR = [(glycemia (mg/dL)) x (insulinemia (μU/mL))] / 405 (7), and non-HDL cholesterol by the formula: total cholesterol - HDL-c (7). No diabetic patients were considered for HOMA-IR analysis.
Resistance (R) and capacitance (Xc) were obtained with direct segmental multifrequency bioelectrical impedance analysis (DSM-BIA) (INBODY 720®), and impedance (Z) was calculated by the software in the equipment. Phase angle (in degrees) was calculated as follows: arctan Xc/R. We considered phase angle values under 5° as low (3). Percentage skeletal muscle mass (SMM) was calculated as % SMM - (skeletal muscle mass x 100) / weight), and skeletal muscle mass was determined by DSM-BIA in kilograms.
Weight was obtained with the same equipment following the protocol indicated by the manufacturer (Biospace®). Height was measured using a stadiometer with a gradation of 1 mm. Body mass index was calculated and classified using the WHO recommendations (8). Waist circumference was measured by a trained team, and values higher than 90 cm (cutoff point for individuals from Central and South America) were considered elevated (9).
The criteria used for MetS diagnosis were proposed by the Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention (9). We considered to be dysglycemia any alterations of glucose metabolism such as elevated fasting plasma glucose (glycemia ≥ 100 mg/dL), glucose intolerance, or diabetes mellitus as defined by Alberti et al. (9). The dyslipidemia criteria used were those proposed by Faludi et al. (7).
Hyperuricemia was defined as an uric acid > 6 mg/dL and > 7 mg/dL in women and men, respectively (10). The medical team diagnosed diabetes and hypertension on the basis of cutoff points for blood pressure and fasting plasma glucose, also as described by Alberti et al. (9).
STATISTICAL ANALYSIS
The statistical package SPSS for Windows® v. 16.0 was used for the analysis. Quantitative variables are presented as mean and standard deviation (SD) or median and interquartile range. Categorical variables are shown as absolute and relative frequencies.
The subjects were divided into two groups using the cutoff point for phase angle, and classified into low phase angle “yes” or “no”. The groups were compared using Student’s t-test and the Mann-Whitney and Chi-squared tests. Correlations were calculated using Pearson’s and Spearman’s correlation tests. After the initial analysis, the variables that showed a p value < 0.20 between groups were adjusted in the logistic regression (waist circumference, dysglycemia, arterial hypertension, and hyperuricemia; the others were not included because of collinearity). P values < 0.05 were considered statistically significant.
ETHICS
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Human Research Ethics Committee at a local institution under the code number 1.534.548/2016. Patient records were received by the clinic in an Excel 2010 file, without names or any other patient identifiers.
RESULTS
The sample consisted of 141 subjects referred for bariatric surgery with an average (standard deviation) age of 37.9 (10.7) years, and the majority were women (80.1 %). Their BMI ranged from 35.0 to 64.0 kg/m2 and their phase angle from 3.32 ° to 7.21 °. Other demographics and clinical data are presented in table I.
*Average (standard deviation); †Median (interquartile range); ‡Diabetic patients were excluded to calculate HOMA-IR. MetS: metabolic syndrome; BMI: body mass index; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; HbA1c: glycated hemoglobin; LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol; VFA: visceral fat area; % SMM: (skeletal muscle mass x 100)/weight.
Table II describes subject characteristics according to phase angle. It was observed that those with a low phase angle had higher BMI, WC, and glycated hemoglobin values. Moreover, they presented more hyperuricemia, arterial hypertension, dysglycemia, and metabolic syndrome, although these differences did not reach statistical significance. However, the regression analysis showed an association between hyperuricemia and low phase angle.
*Average (standard deviation); †Median (interquartile range); ‡Diabetic patients were excluded to calculate HOMA-IR; §Variables included in the regression model: waist circumference, dysglycemia, arterial hypertension and hyperuricemia. MetS: metabolic syndrome; BMI: body mass index; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; HbA1c: glycated hemoglobin; LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol; VFA: visceral fat area; % SMM: (skeletal muscle mass x 100)/weight; TGL: triglycerides.
The correlations between metabolic parameters, body composition variables, and phase angle are shown in table III. There was no statistically significant linear association between them.
DISCUSSION
Our findings showed that obese patients with low values of phase angle, an indicator of membrane integrity, presented a higher prevalence of hyperuricemia, even after adjustment for waist circumference, dysglycemia, and arterial hypertension.
Obesity is characterized by subclinical inflammation with important changes in the metabolic profile that contribute to a high cardiovascular risk. This profile frequently consists of dysglycemia and/or insulin resistance, elevation of triglycerides, and/or reduction of HDL-c, and in many cases hyperuricemia (4,5). This inflammatory condition is highlighted by an increase in markers of inflammation such as interleukin 6 (IL-6), C-reactive protein (CPR), PAI-1 (plasminogen activator inhibitor 1), leptin, and others (1,4).
This metabolic profile observed in very obese patients is associated with changes in body fluid distribution and reduced cellular integrity that can be estimated by phase angle (PA) measurement (10). This indicator is calculated based on impedance, which is determined by tetrapolar bioimpedance equipment. This analysis is a simple, fast, noninvasive, and safe technique for measuring human electrical tissue conductivity (2). The opposition of tissues to an alternating electric current presents two components: resistance (R) and reactance or capacitance (Xc). The first one is the capacity of tissues to restrict the flow of the current through the body, and is directly related to the amount of water present in the tissue. Capacitance is the resistive effect produced by the tissue and cell membranes that store part of the electric current, acting as a capacitor and creating a phase shift that is geometrically determined as PA (11).
Phase angle has been used as a good prognostic factor for postoperative complications, for different types of surgery, even after adjusting for individual confounders (3). It has also been proposed as a prognostic indicator for weight loss in patients undergoing bariatric surgery. Studies observed that lower values of baseline PA in those patients are associated with insufficient weight loss (2,12), suggesting that inflammation status in the preoperative period can be a determinant of surgery success. In our sample, approximately one third of patients presented with low PA, which indicates low cell integrity, and led us to hypothesize the presence of inflammation.
Although some studies indicate that low PA is also associated with some body composition components such as muscle mass and total body water (2,13), no statistically significant correlation was found between PA and percentage of skeletal muscle mass (% SMM) or other components evaluated in our study. We used the cutoff point of 5.0 ° proposed by Norman et al. (2012) (3) for the determination of low PA, as there is no reference value for our population, to our knowledge.
In our results, low PA was associated with hyperuricemia, even after adjustment for waist circumference, dysglycemia, arterial hypertension, and hyperuricemia. There was no separate association between PA and these other conditions. Hyperuricemia is a condition very often found in the obese population, including in our sample, and also associated with inflammation and higher cardiovascular risk (14,15).
The results of Kennan et al. (2012) suggest that the increased cardiovascular risk associated with hyperuricemia precedes obesity or metabolic syndrome, and that higher levels of uric acid increase the risk for a cardiovascular outcome by a factor of 2-3 (14). It seems that uric acid contributes to oxidative stress, decreases the release of anti-inflammatory adipokines, and increases that of proinflammatory ones (16), but its contribution to cardiovascular events, as an independent factor, has not been settled (17,18). Considering the recognized contribution of uric acid to cardiovascular risk, our results led us to believe that a low PA in severe obese individuals could be used to evaluate cardiovascular risk in this population.
We found no significant correlation between PA and fasting glycemia or between PA and HbA1c, a long-term marker of glycemic control; however, for the latter, a tendency toward significance was found. This might indicate that exposure to high glycemic levels can affect cellular integrity (19).
The small number of patients enrolled in the study due to missing BIA results and some metabolic information could be a limitation of our study; nevertheless, only a few studies have investigated PA in very obese patients. This group, mainly when undergoing bariatric surgery, needs effective indicators to evaluate possible complications.
Our study shows the association between low phase angle and uric acid, and a tendency for them to be correlated with HbA1c in the presence of severe obesity. This association suggests that PA can indicate an unfavorable metabolic profile in those patients. Studies with higher numbers of participants should be conducted to further investigate the use of PA as an indicator of the metabolic profile.